Serial entrepreneur and precision medicine technologist to drive strategic agenda at BC Platforms ZURICH, July 03, 2024 (GLOBE NEWSWIRE) — BC Platforms, a global leader in real world data, healthcare data management, and analytics, today announces the appointment of a new Chairman of the Board. Alex is a seasoned executive with deep experience at the […]
Category Archives: Pr Newswire
Pr Newswire
Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical Results
03
Jul
Jul
Company to Host Webcast on 12th July at 9am AEST (7pm ET, 11 July) SYDNEY, AUSTRALIA, July 03, 2024 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces details for an upcoming oral presentation at the […]
03
Jul
Jul
Focus on vebreltinib study enrollment for non-small cell lung cancer (NSCLC) patients with Met Amplification mutations targets greatest unmet medical need FOSTER CITY, Calif., July 03, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, announced […]
ISLAMABAD, July 3, 2024 /PRNewswire/ — REFORMING THE POWER SECTOR IN PAKISTAN Honorable Minister of Power Pakistan, Mr. Awais Leghari The power sector in Pakistan faces a myriad of serious and complex issues, ranging from bad governance to delays in decision-making and lack of economic growth. These challenges have led to inefficiencies that are embedded […]
HONG KONG, July 3, 2024 /PRNewswire/ — Hangzhou SF Intra-city Industrial Co., Ltd. (“SF Intra-city”, or the “Group”; Stock Code: 9699.HK), China’s largest third-party on-demand delivery service provider, officially launched the “SoFast” brand in Hong Kong on 1 July, 2024. It marks the first time the Group extended its on-demand delivery service beyond mainland China, signifying […]
SHANGHAI, July 3, 2024 /PRNewswire/ — U Power Limited (Nasdaq: UCAR) (the “Company” or “U Power”), a vehicle sourcing services provider with a vision to becoming a comprehensive electric EV battery power solution provider in China, today announced that it had signed a Memorandum of Understanding (“MoU”) with Pattaya AI Terminal Co., Ltd. (“Pattaya AI”) […]
BEIJING, July 3, 2024 /PRNewswire/ — A farmer painting invitational exhibition was recently held in Donggang District of Rizhao City, east China’s Shandong Province, presenting more than 300 artworks from 19 provinces and regions in China. Vividly depicting picturesque scenery such as water-bound towns in the lower reaches of the Yangtze River, bountiful grain harvest […]
WUHAN, China, July 3, 2024 /PRNewswire/ — DouYu International Holdings Limited (“DouYu” or the “Company”) (Nasdaq: DOYU) a leading game-centric live streaming platform in China and a pioneer in the eSports value chain, today announced that the Company’s board of directors approved and declared a special cash dividend of US$9.76 per ordinary share, or US$9.76 […]
03
Jul
Jul
VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, announced that it has closed a non-brokered private placement, previously announced on June 13, 2024, pursuant […]
Pr Newswire
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination
03
Jul
Jul
Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. (Nasdaq: DECA) (“SPAC”) announce signing of a letter of intent for a proposed business combination, which provides for a pre-transaction equity value of Semnur of up to $2.0 billion, subject to adjustment based on third-party […]